Drug profile

The FDA adverse-event record for Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim

1,949 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim. See the species affected, top reactions, and outcomes below.

1,949
adverse-event reports
9.3%
death-coded share
Dog
most-reported species
816
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,949
Total Reports
181
Deaths Reported
9.3%
Death Rate

Active Ingredients

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim

Administration Routes

OralNasalUnknownSubcutaneousSublingualOtherOphthalmic

Species Affected

Dog 1,948
Unknown 1

Most Affected Breeds

Retriever - Labrador 151
Terrier - Bull - American Pit 114
Chihuahua 114
Terrier - Yorkshire 102
Retriever - Golden 83
Shih Tzu 80
Boxer (German Boxer) 72
Shepherd Dog - Australian 59
Crossbred Canine/dog 57
Terrier (unspecified) 54

Most Reported Reactions

Vomiting 816
Lethargy (see also Central nervous system depression in 'Neurological') 344
Anaphylaxis 298
Facial swelling (see also 'Skin') 282
Diarrhoea 246
Pale mucous membrane 192
Hives (see also 'Skin') 191
Lethargy (see also Central nervous system depression in Neurological) 169
Fever 135
Facial swelling (see also Skin) 108
Not eating 101
Death 100

Outcome Breakdown

Ongoing
1,010 (51.8%)
Recovered/Normal
663 (34.0%)
Died
104 (5.3%)
Outcome Unknown
93 (4.8%)
Euthanized
77 (4.0%)
Recovered with Sequela
1 (0.1%)

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim Adverse Event Insights

1,949 reports name Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim; 181 recorded a death outcome (9.3% of reported events, not a population-level mortality rate). Active ingredient: Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim. Administration routes: Oral, Nasal, Unknown, Subcutaneous.

By species: Dog (1,948 reports), Unknown (1 reports). By breed: Retriever - Labrador (151), Terrier - Bull - American Pit (114), Chihuahua (114).

Leading clinical signs: Vomiting (816), Lethargy (see also Central nervous system depression in 'Neurological') (344), Anaphylaxis (298), Facial swelling (see also 'Skin') (282). Outcome, 1,948 coded reports: Ongoing leads at 51.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.